0.011
price down icon50.45%   -0.0112
after-market Handel nachbörslich: .01 -0.0010 -9.09%
loading

Finanzdaten der T 2 Biosystems Inc-Aktie (TTOO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
22.75%
2.061
1.679 1.472 1.964 2.078
Operating Expenses
33.31%
14.66
11.00 15.08 15.02 15.77
Benefits Costs and Expenses
29.75%
15.60
12.02 15.08 15.02 20.04
Costs And Expenses
33.31%
14.66
11.00 15.08 15.02 15.77
Depreciation and Amortization
0.00%
0.10
0.10 0.10 0.10 0.30
Operating Income/Loss
35.21%
-12.60
-9.319 -13.61 -13.05 -13.69
Nonoperating Income/Loss
8.52%
-0.934
-1.021 -1.818 6.704 -4.278
Income/Loss From Continuing Operations Before Tax
30.89%
-13.53
-10.34 -13.61 -6.347 -17.96
Income/Loss From Continuing Operations After Tax
30.89%
-13.53
-10.34 -15.43 -6.347 -17.96
Net Income/Loss
30.89%
-13.53
-10.34 -15.43 -6.347 -17.96
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
547.78%
5.0948
0.7865 4.4773 80.92 13.63
Diluted Average Shares
547.78%
5.0948
0.7865 4.4773 80.92 13.63
Basic Earnings Per Share
202.31%
-2.66
2.60 -3.45 -0.08 -1.32
Diluted Earnings Per Share
202.31%
-2.66
2.60 -3.45 -0.08 -1.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research WAT
$334.59
price down icon 0.08%
diagnostics_research DGX
$189.51
price up icon 1.44%
diagnostics_research LH
$285.94
price up icon 0.79%
$181.69
price up icon 0.64%
diagnostics_research MTD
$1,349.28
price down icon 0.76%
diagnostics_research IQV
$204.55
price down icon 0.58%
Kapitalisierung:     |  Volumen (24h):